Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Meerovitch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Thiophene-based vitronectin receptor antagonistsMonica Bubenik, Karen Meerovitch, Frédéric Bergeron, et al.
Experimental Eye Research|July 6, 2011
An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eyePooja Jain, Ruihong Li, Teresa Lama, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 10, 2013
Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eyeKaren Meerovitch, Gail Torkildsen, John Lonsdale, et al.
The Journal of Biological Chemistry|June 28, 2005
Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replicationSarah Welbourn, Robin Green, Isabelle Gamache, et al.
The Journal of Biological Chemistry|August 15, 2008
Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucomaZhiHua Shi, Marcelo Rudzinski, Karen Meerovitch, et al.
Vascular Pharmacology|March 21, 2003
A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagenKaren Meerovitch, Frédéric Bergeron, Lorraine Leblond, et al.
Molecular Cancer Therapeutics|November 16, 2004
Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activityShailaja Kasibhatla, Henriette Gourdeau, Karen Meerovitch, et al.
Chemistry & Biology|March 2, 2010
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivityWenyong Tong, Martin Gagnon, Tara Sprules, et al.
Journal of Medicinal Chemistry|November 30, 2004
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl groupWilliam Kemnitzer, John Drewe, Songchun Jiang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Thiophene-based vitronectin receptor antagonistsMonica Bubenik, Karen Meerovitch, Frédéric Bergeron, et al.
Experimental Eye Research|July 6, 2011
An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eyePooja Jain, Ruihong Li, Teresa Lama, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 10, 2013
Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eyeKaren Meerovitch, Gail Torkildsen, John Lonsdale, et al.
The Journal of Biological Chemistry|June 28, 2005
Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replicationSarah Welbourn, Robin Green, Isabelle Gamache, et al.
The Journal of Biological Chemistry|August 15, 2008
Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucomaZhiHua Shi, Marcelo Rudzinski, Karen Meerovitch, et al.
Vascular Pharmacology|March 21, 2003
A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagenKaren Meerovitch, Frédéric Bergeron, Lorraine Leblond, et al.
Molecular Cancer Therapeutics|November 16, 2004
Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activityShailaja Kasibhatla, Henriette Gourdeau, Karen Meerovitch, et al.
Chemistry & Biology|March 2, 2010
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivityWenyong Tong, Martin Gagnon, Tara Sprules, et al.
Journal of Medicinal Chemistry|November 30, 2004
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl groupWilliam Kemnitzer, John Drewe, Songchun Jiang, et al.
Pageof 1